Shares of Arena Pharmaceuticals rose 3.3% to $71.47 at 12:05 EST on Monday, following yesterday’s downward trend. The Nasdaq Stock Market is rising 1.19% to $12,525.60, following yesterday’s downward trend, This seems, up to now, an all-around positive trend trading session today.

Arena Pharmaceuticals’s last close was $69.19, 26.19% under its 52-week high of $90.19.

Arena Pharmaceuticals’s Sales

Arena Pharmaceuticals’s sales growth is a negative 81.3% for the ongoing quarter and 155.7% for the next. The company’s growth estimates for the ongoing quarter is a negative 4.5% and positive 4.5% for the next.

Arena Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth declined by 98.5%, now sitting on 3.28M for the twelve trailing months.

Arena Pharmaceuticals’s Stock Top and Bottom Yearly Value

Arena Pharmaceuticals’s stock is valued at $71.47 at 12:05 EST, way under its 52-week high of $90.19 and way higher than its 52-week low of $32.95.

Arena Pharmaceuticals’s Moving Average

Arena Pharmaceuticals’s value is below its 50-day moving average of $72.71 and above its 200-day moving average of $69.20.


Please enter your comment!
Please enter your name here